📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
224 announcements match the current filters (relevance ≥ 5).
NH to Hold NCLT-Directed Meetings on April 2, 2026, for Scheme of Arrangement
Narayana Hrudayalaya (NH) has announced NCLT-convened meetings on April 2, 2026, to seek approval for a Scheme of Arrangement with NH Integrated Care Private Limited. The restructuring involves a demerger from NH Integrated Care into NH as the resulting company. Separate meetings are scheduled for equity shareholders, secured creditors, and unsecured creditors throughout the day. Remote e-voting for eligible stakeholders will be conducted from March 30 to April 1, 2026.
Key Highlights
NCLT-directed meetings for shareholders and creditors scheduled for April 2, 2026, via video conferencing.
Scheme involves the demerger of business from NH Integrated Care Private Limited into Narayana Hrudayalaya Limited.
Remote e-voting period is set from March 30, 2026 (9:00 AM) to April 1, 2026 (5:00 PM).
Separate voting sessions for Secured Creditors (11:30 AM) and Unsecured Creditors (12:30 PM) follow the shareholder meeting.
The arrangement is subject to final approval from the NCLT Bengaluru Bench and other regulatory bodies.
👀 What to Watch
Investors should monitor the outcome of the April 2nd meetings as the approval is a critical milestone for the company's internal restructuring. Review the scheme details to understand how the integration of NH Integrated Care's business will impact the consolidated financials.
Narayana Hrudayalaya Sets April 2 Meeting for Scheme of Arrangement with NH Integrated Care
Narayana Hrudayalaya (NH) has convened a meeting of its equity shareholders and creditors on April 2, 2026, following directions from the NCLT Bengaluru Bench. The primary objective is to seek approval for a Scheme of Arrangement involving the demerger of NH Integrated Care Private Limited into Narayana Hrudayalaya Limited. Shareholders can exercise their voting rights through remote e-voting between March 30 and April 1, 2026. This procedural step is essential for the company's internal corporate restructuring and consolidation efforts.
Key Highlights
Shareholders' meeting scheduled for April 2, 2026, at 10:00 A.M. via video conferencing.
Scheme involves the demerger of NH Integrated Care Private Limited into Narayana Hrudayalaya Limited.
Remote e-voting period is set from March 30, 2026 (9:00 A.M.) to April 1, 2026 (5:00 P.M.).
Separate meetings for Secured Creditors (11:30 A.M.) and Unsecured Creditors (12:30 P.M.) on the same day.
The restructuring is being conducted under Sections 230 to 232 of the Companies Act, 2013.
👀 What to Watch
Shareholders should review the detailed Scheme of Arrangement and explanatory statements provided by the company to understand the impact on their holdings. It is advisable to participate in the e-voting process to ensure representation in this significant corporate action.
NH Q3 FY26 Earnings: India Business Margins Expand 150-200 bps YoY
Narayana Hrudayalaya (NH) reported a strong Q3 FY26 performance with its India business achieving a significant margin expansion of 150-200 basis points YoY. This growth was driven by payor mix optimization and a shift toward high-end procedures like robotic cardiac surgeries and bone marrow transplants, particularly in the Bangalore cluster. While the insurance and clinic segments remain in the investment phase with no immediate breakeven timeline, management is focusing on cost synergies. Despite rising competition in Bangalore and North India, the company maintains a positive outlook on domestic volume consolidation.
Key Highlights
India business margins expanded by 150-200 basis points YoY due to transformation programs and payor mix optimization.
Bangalore cluster saw high realizations driven by leadership in robotic cardiac surgeries and bone marrow transplants.
Management is consciously reducing low-margin government scheme volumes in the North cluster to improve overall realizations.
Clinics are being merged into the main NHL entity to better manage synergies and minimize margin dilution.
The company is actively working on licensing to convert its Mumbai pediatric hospital into a multi-specialty adult facility.
👀 What to Watch
Investors should view the margin expansion and shift toward high-end robotic procedures as a structural positive for long-term profitability. Monitor the North cluster's recovery and the impact of new competition in the Bangalore market over the coming quarters.
Canara HSBC Life Receives 'CARE AA+; Stable' Rating for Proposed ₹250 Cr Subordinate Debt
Canara HSBC Life Insurance has received a high-grade 'CARE AA+; Stable' credit rating from CARE Ratings Limited for its proposed ₹250 crore subordinate debt issue. This rating signifies a very high degree of safety regarding timely servicing of financial obligations and very low credit risk. The capital raised through this instrument is expected to strengthen the company's solvency margin and support business growth. The rating is valid for six months from February 18, 2026, provided the terms of the issue remain unchanged.
Key Highlights
CARE Ratings assigned 'CARE AA+; Stable' rating to the proposed ₹250 crore Subordinate Debt issue.
The rating indicates a very high degree of safety and low credit risk for potential debt investors.
The company must complete the proposed issue within six months to maintain the current rating validation.
The rating is subject to at least one surveillance review every year by the credit rating agency.
The issuance will likely bolster the company's capital base and regulatory solvency requirements.
👀 What to Watch
Investors should view this high credit rating as a positive indicator of the company's financial stability and creditworthiness. Monitor the successful closure of the debt issuance as it will improve the company's capital adequacy.
NHPC Faces Arbitral Award of ₹227.82 Cr Plus Interest in Dispute with HCC
NHPC Limited has received an adverse arbitral award regarding the Kishanganga HE Project in favor of Hindustan Construction Company (HCC). The award includes a principal amount of ₹227.82 Crore and EUR 2.66 million, plus significant interest charges ranging from 10.40% to 12.40% per annum. While the award is currently under examination, NHPC has filed counter-claims totaling ₹738.67 Crore which are yet to be argued. This development represents a potential financial liability for NHPC, depending on the outcome of its counter-claims and potential appeals.
Key Highlights
Arbitral Tribunal awarded HCC ₹227.82 Crore and EUR 26,66,029 in principal amounts.
Award includes pre-reference and pendente lite interest at 10.40% p.a. and future interest at 12.40% p.a.
NHPC has filed counter-claims worth ₹738.67 Crore against HCC, with arguments yet to commence.
The dispute relates to the Kishanganga HE Project involving civil works, tax changes, and retention money.
Arbitration costs of ₹1.57 Crore and USD 10,000 were also awarded against NHPC.
👀 What to Watch
Investors should monitor whether NHPC challenges this award in a higher court and track the progress of the ₹738.67 Crore counter-claim which could potentially offset this liability.
NHPC Approves ₹5,703 Crore Investment for 500 MW Hydro Projects in J&K
NHPC's board has approved investment proposals for two major hydroelectric projects in Jammu & Kashmir with a combined capacity of 500 MW. The Uri-I Stage-II (240 MW) project is estimated to cost ₹2,708.95 crore, while the Dulhasti Stage-II (260 MW) project is budgeted at ₹2,993.96 crore. Construction for both projects is scheduled to commence on March 1, 2026, pending final implementation agreements with the UT government. This move represents a significant capital expenditure aimed at long-term capacity growth.
Key Highlights
Approved Uri-I Stage-II HE Project (240 MW) with an estimated cost of ₹2,708.95 Crore
Approved Dulhasti Stage-II HE Project (260 MW) with an estimated cost of ₹2,993.96 Crore
Total combined investment outlay for both projects is approximately ₹5,702.91 Crore
Construction start date for both projects is targeted for March 1, 2026
Projects include specific allocations for Interest During Construction (IDC) and enabling infrastructure
👀 What to Watch
Investors should look at this as a positive long-term capacity expansion that strengthens NHPC's dominant position in the hydro-power sector. Monitor the signing of the formal implementation agreements with the J&K government as the next key catalyst.
Narayana Hrudayalaya Acquires 3.3-Acre Property in Bengaluru for GCC and Expansion
Narayana Hrudayalaya (NH) has purchased approximately 3.3 acres of land in Electronic City, Bengaluru, including 36,475.96 square meters of built-up area. The facility is designated for software development and the establishment of a Global Capability Center (GCC) to support business expansion. This move indicates a strategic shift towards strengthening in-house technological infrastructure and operational efficiency. The acquisition is a significant step in the company's long-term growth and digital transformation roadmap.
Key Highlights
Acquisition of 3.3 acres of land in the southern part of Bengaluru (Electronic City).
Includes existing buildings and structures measuring approximately 36,475.96 square meters.
Purpose includes software development and setting up a Global Capability Center (GCC).
Strategic move to support the company's broader business expansion plans.
👀 What to Watch
Investors should view this as a positive long-term infrastructure investment that could enhance operational efficiency. Watch for further disclosures regarding the cost of acquisition and the timeline for the GCC's operationalization.
Canara HSBC Life Insurance Assigned CRISIL AA+/Stable Rating for ₹250 Crore Debt
Canara HSBC Life Insurance has received a 'CRISIL AA+/Stable' credit rating for its proposed ₹250 crore subordinated debt issuance. This high-grade rating indicates a very low risk of default and reflects the company's strong financial profile and parentage support from Canara Bank and HSBC. The rating is a crucial step for the company to raise Tier II capital to strengthen its solvency and fund future growth. The stable outlook suggests that CRISIL expects the company to maintain its healthy market position and capitalization levels.
Key Highlights
CRISIL Ratings assigned 'CRISIL AA+/Stable' rating for proposed ₹250 crore subordinated debt.
The rating pertains to the company's plan to raise Tier II capital through debt instruments.
The 'Stable' outlook reflects expectations of continued support from promoters and robust solvency margins.
The announcement was made in compliance with Regulation 30 of SEBI (LODR) Regulations, 2015.
👀 What to Watch
Investors should take this as a positive indicator of the company's creditworthiness and its ability to raise capital at competitive rates. Monitor the successful placement of this debt and its impact on the company's capital adequacy ratio.
Canara HSBC Life Insurance Reaffirmed 'CARE AAA; Stable' Issuer Rating
CARE Ratings Limited has reaffirmed the 'CARE AAA; Stable' issuer rating for Canara HSBC Life Insurance Company Limited. This rating reflects the company's strong general creditworthiness and the highest degree of safety regarding financial obligations. The reaffirmation is based on a review of the company's audited FY25 performance and unaudited 9MFY26 results. This top-tier rating underscores the company's stable financial position and robust operational framework.
Key Highlights
Issuer rating reaffirmed at 'CARE AAA' with a 'Stable' outlook by CARE Ratings.
Review included audited financial performance for FY25 and unaudited data for 9MFY26.
The 'AAA' rating signifies the highest level of creditworthiness in the Indian market.
The rating is an opinion on general creditworthiness and not specific to any single debt instrument.
👀 What to Watch
The reaffirmation of the highest credit rating confirms the company's financial strength; shareholders can remain confident in the management's ability to maintain a low-risk profile.
Canara HSBC Life Seeks Shareholder Approval for AoA Amendment and FY26 Related Party Transactions
Canara HSBC Life Insurance has issued a postal ballot notice to amend its Articles of Association, formalizing director nomination rights for its promoters, Canara Bank and HSBC Insurance. Under the proposed terms, Canara Bank will nominate three directors and HSBC will nominate two, with the rights shifting if shareholding proportions change. The company is also seeking approval for material related party transactions with both promoters for the 2025-26 financial year. Shareholders can participate in the e-voting process from February 18, 2026, to March 19, 2026.
Key Highlights
Proposed AoA amendment allows Canara Bank to nominate 3 directors and HSBC to nominate 2 directors.
Nomination rights will flip (HSBC 3, Canara Bank 2) if HSBC's shareholding exceeds Canara Bank's.
Seeking approval for material Related Party Transactions with Canara Bank and HSBC for FY 2025-26.
E-voting period is scheduled from February 18, 2026, to March 19, 2026, with results by March 23, 2026.
The Board size is defined to be between 3 and 12 directors, including independent and women directors.
👀 What to Watch
Investors should monitor the voting results to ensure the governance framework remains stable between the two primary promoters. The approval of related party transactions is critical for the company's operational continuity given its bancassurance model.
Asian Hotels (North) Q3 Revenue Up 5% to ₹91 Cr; Debt Fully Resolved via ₹765 Cr Fundraise
Asian Hotels (North) reported a 5.2% YoY increase in Q3 FY26 revenue to ₹90.98 crore, though it posted a net loss of ₹56.47 crore primarily due to ₹40.28 crore in exceptional penal charges on debt defaults. The company faced significant financial stress during the quarter with defaults on principal and interest totaling approximately ₹674 crore. However, a major structural turnaround occurred post-quarter as the company raised ₹764.94 crore through a preferential issue at ₹330 per share. These funds were entirely utilized to repay all outstanding borrowings, effectively clearing the company's debt and supporting its status as a going concern.
Key Highlights
Revenue from operations increased to ₹9,098.44 lakhs in Q3 FY26 from ₹8,646.67 lakhs in Q3 FY25.
Reported a net loss of ₹5,647.37 lakhs for the quarter, heavily impacted by exceptional penal interest charges of ₹4,027.63 lakhs.
Successfully raised ₹76,494 lakhs post-quarter through a preferential issue of 2.31 crore equity shares at ₹330 per share.
Entire proceeds of the fundraise were used to settle all outstanding principal and interest defaults, resolving the company's debt crisis.
Finance costs for the nine-month period ended Dec 2025 dropped significantly to ₹5,837.26 lakhs from ₹10,099.28 lakhs YoY.
👀 What to Watch
The complete resolution of debt via a massive equity infusion is a transformative event that removes the primary bankruptcy risk for the company. Investors should now focus on the operational efficiency of the Hyatt Regency Delhi property to see if the company can achieve sustainable net profitability in a debt-free environment.
NH Q3 FY26 Revenue Surges 61% YoY to ₹21,512 Mn; Adj. PAT Up 31.6%
Narayana Hrudayalaya reported a massive 61.2% YoY revenue growth in Q3 FY26, driven by the consolidation of the newly acquired Practice Plus Group in the UK and strong performance in the Cayman Islands. While Adjusted EBITDA grew 43.1% YoY to ₹4,662 Mn, reported PAT fell 33.9% to ₹1,281 Mn due to one-time acquisition costs of ₹757 Mn and a ₹509 Mn impact from the new labor code. The India business grew steadily at 11.8% YoY, while the Cayman segment saw a robust 70% YoY revenue jump. Net debt increased to ₹22,321 Mn following international expansion, resulting in a net debt-to-equity ratio of 0.53.
Key Highlights
Consolidated revenue jumped 61.2% YoY to ₹21,512 Mn, including ₹4,902 Mn from the new UK operations consolidated since Nov 6, 2025.
Adjusted EBITDA stood at ₹4,662 Mn with a margin of 21.7%, though reported margins were diluted by one-time acquisition costs.
Cayman Islands revenue grew 70% YoY to ₹4,991 Mn, reflecting strong synergy between hospital and insurance businesses.
India operations maintained steady growth of 11.8% YoY to ₹11,796 Mn, driven by payor mix optimization.
Reported PAT was impacted by ₹1,266 Mn in total one-time adjustments related to the UK acquisition and new labor code provisions.
👀 What to Watch
Investors should look past the one-time reported profit dip and focus on the strong 43% growth in Adjusted EBITDA and successful international scaling. The integration of the UK business and continued momentum in Cayman provide significant long-term growth levers.
NH Q3 FY26 Revenue Surges 61.2% YoY to ₹21,512 Mn Driven by UK Acquisition and Cayman Growth
Narayana Hrudayalaya (NH) reported a massive 61.2% YoY revenue jump in Q3 FY26, reaching ₹21,512 Mn, largely due to the first-time consolidation of its UK operations and 70% growth in the Cayman Islands. While reported PAT declined 33.9% YoY to ₹1,281 Mn, this was impacted by one-time acquisition costs of ₹757 Mn and a ₹509 Mn labor code provision. Adjusted for these items, PAT actually grew 31.6% YoY to ₹2,548 Mn. The company is maintaining an aggressive expansion strategy, targeting over 7,600 beds by FY30 with significant projects underway in Bangalore and Kolkata.
Key Highlights
Consolidated Revenue grew 61.2% YoY to ₹21,512 Mn, including ₹4,902 Mn contribution from newly acquired UK operations.
Adjusted EBITDA (excluding one-time costs) rose 43.1% YoY to ₹4,662 Mn with a healthy margin of 21.7%.
India hospital ARPOB improved significantly to ₹18.1 Mn compared to ₹15.8 Mn in the same quarter last year.
Cayman Islands revenue grew 70% YoY to ₹4,991 Mn, showing strong international momentum.
Net debt-to-equity remains manageable at 0.53 despite the significant UK acquisition and ongoing capex.
👀 What to Watch
Investors should focus on the strong underlying operational growth and the successful integration of international assets, ignoring the temporary dip in reported PAT caused by one-time acquisition expenses. The stock remains a long-term growth play given the aggressive 1,300+ bed capacity addition planned by FY30.
NH Q3 Standalone Revenue up 12% YoY; Net Profit hit by ₹452.7M Exceptional Labour Code Charge
Narayana Hrudayalaya (NH) reported a 12% YoY increase in standalone revenue to ₹9,687.8 million for the quarter ended December 31, 2025. Operational performance was strong, with EBITDA rising 33.4% YoY to ₹2,206.1 million, indicating improved margins. However, net profit fell 4.4% YoY to ₹757.3 million, primarily due to a one-time exceptional charge of ₹452.76 million related to the implementation of new Labour Codes. Excluding this non-recurring item, Profit Before Tax grew by a healthy 42.5% YoY, reflecting robust underlying business growth.
Key Highlights
Standalone Revenue from operations grew 12% YoY to ₹9,687.81 million.
EBITDA increased by 33.4% YoY to ₹2,206.15 million, showing strong operational leverage.
Net Profit declined 4.4% YoY to ₹757.37 million due to a ₹452.76 million exceptional charge for Labour Code compliance.
Profit Before Tax (excluding exceptional items) rose 42.5% YoY to ₹1,445.38 million.
Ongoing corporate restructuring includes the merger of Meridian Medical and demerger of clinical services from NHIC.
👀 What to Watch
Investors should focus on the strong operational growth and PBT (excluding exceptions) rather than the headline net profit decline, as the impact is non-recurring. Monitor the progress of the NCLT-led restructuring which aims to streamline subsidiary operations.
NH Q3 FY26 Revenue up 12% YoY to ₹9,688 Mn; Net Profit impacted by ₹453 Mn Exceptional Item
Narayana Hrudayalaya reported a 12% YoY growth in standalone revenue for Q3 FY26, reaching ₹9,687.81 million. However, net profit declined slightly to ₹757.37 million from ₹792.23 million YoY, primarily due to a one-time exceptional charge of ₹452.76 million related to the implementation of new Labour Codes. EBITDA showed strong growth, rising 33.4% YoY to ₹2,206.15 million, reflecting improved operational efficiency despite a sequential dip in revenue compared to Q2 FY26. The company is also progressing with the merger of its subsidiary MMRHL and the demerger of clinical services from NHIC to streamline its corporate structure.
Key Highlights
Standalone Revenue from operations grew 12% YoY to ₹9,687.81 million for the quarter ended December 31, 2025.
EBITDA increased significantly by 33.4% YoY to ₹2,206.15 million, though it declined 10.4% on a sequential (QoQ) basis.
Net Profit was impacted by a ₹452.76 million one-time provision for gratuity and leave liabilities arising from the new Labour Codes.
The merger with subsidiary Meridian Medical Research & Hospital Ltd (MMRHL) has received shareholder approval and is awaiting final NCLT orders.
Incorporated a new wholly-owned subsidiary, Narayana Healthcare North Private Limited, on January 16, 2026, to expand healthcare services.
👀 What to Watch
Investors should focus on the robust 33% YoY EBITDA growth, which indicates strong underlying operational health despite the one-time regulatory hit to the bottom line. The ongoing corporate restructuring and expansion into Northern India are key long-term growth drivers to monitor.
NHPC 9M FY26 PAT Grows 7% to ₹2,306 Cr; Plans 10,000 MW New Project Starts in 2026
NHPC reported a steady 9M FY26 performance with revenue rising 10% YoY to ₹8,800 crore and PAT increasing 7% to ₹2,306 crore, primarily driven by the commissioning of Parbati-II. The company is entering a high-growth phase with the 2,000 MW Subansiri Lower project expected to be fully commissioned by December 2026. Management has guided for a massive expansion, planning to commence work on 10,000 MW of new capacity during 2026. Additionally, the company expects to commission over 1,000 MW of solar power within the current calendar year.
Key Highlights
9M FY26 power generation rose 15% YoY to 25,849 MUs following Parbati-II commissioning.
Subansiri Lower (2,000 MW) update: 2 units operational, 2 more by March 2026, and full completion by Dec 2026.
Planning to start 5-6 new projects totaling ~10,000 MW capacity in 2026, including the 3,097 MW Etalin project.
Renewable expansion: Targeting >1,000 MW solar commissioning in 2026 and starting ~2,000 MW of Pumped Storage Plants.
9M FY26 Revenue from Operations stood at ₹8,800 Crore, up 10% from ₹8,033 Crore in the previous year.
👀 What to Watch
Investors should maintain a positive outlook as NHPC transitions from a construction-heavy phase to a commissioning phase for major projects like Subansiri Lower. The massive 10,000 MW pipeline and entry into Pumped Storage provide strong long-term visibility for regulated equity growth.
Indian Hume Pipe Q3 PAT Surges to ₹61.5 Cr Driven by ₹64.3 Cr Land Sale Gain
Indian Hume Pipe reported a significant jump in Net Profit to ₹61.51 crore for Q3 FY26, compared to ₹14.37 crore in the same period last year. However, this growth was primarily driven by an exceptional gain of ₹64.33 crore from the sale of freehold land in Hyderabad. Revenue from operations actually declined by 25.9% YoY to ₹282.06 crore, reflecting a slowdown in the core construction segment. While finance costs improved, the underlying operational profit before exceptional items saw a decline of approximately 19% YoY.
Key Highlights
Net Profit rose 328% YoY to ₹61.51 crore, heavily boosted by a ₹64.33 crore exceptional gain from land sale.
Revenue from operations fell 25.9% YoY to ₹282.06 crore from ₹380.62 crore in the previous year's quarter.
Profit before exceptional items and tax stood at ₹15.78 crore, down from ₹19.55 crore YoY.
Finance costs reduced significantly to ₹11.77 crore from ₹15.97 crore in the previous year's quarter.
EPS for the quarter increased to ₹11.67 from ₹2.73 in Q3 FY25.
👀 What to Watch
Investors should look past the headline profit surge as it is driven by a one-time asset sale rather than core business growth. The decline in construction segment revenue and operational profit warrants caution; monitor the order book for signs of recovery.
Indian Hume Pipe Q3 Profit Jumps to ₹61.5 Cr on Land Sale; Revenue Down 26% YoY
Indian Hume Pipe reported a 328% YoY surge in Q3 Net Profit to ₹61.51 crore, largely due to a ₹64.33 crore exceptional gain from selling land in Hyderabad. Revenue from operations declined 25.9% YoY to ₹282.06 crore, attributed to billing delays in major government projects like the Jal Jeevan Mission. Despite the revenue dip, the company saw a credit rating upgrade to 'A' and strong progress in its Pune real estate joint ventures, receiving ₹164.26 crore in cash flows. The order book remains robust at ₹3,549.07 crore, indicating a stable future pipeline.
Key Highlights
Net Profit increased to ₹61.51 Cr from ₹14.37 Cr YoY, aided by a ₹64.33 Cr land sale gain.
Revenue from operations fell to ₹282.06 Cr from ₹380.62 Cr due to elongated billing cycles in government projects.
Credit ratings upgraded to A (Long-term) and A1 (Short-term) reflecting improved financial health.
Order book stands at ₹3,549.07 Cr with an additional L1 position in a project worth ₹625.94 Cr.
Real estate monetization in Pune has generated ₹164.26 Cr in cash flows to date across two major projects.
👀 What to Watch
While the profit surge is non-operational, the credit upgrade and real estate cash flows are strong positives; investors should watch for core revenue recovery as billing cycles normalize in FY27.
Indian Hume Pipe Q3 PAT Jumps 328% to ₹61.5 Cr; Revenue Declines 26% YoY
Indian Hume Pipe reported a significant 328% YoY increase in Net Profit to ₹61.51 crore for Q3 FY26, though this was primarily driven by a one-time exceptional gain of ₹64.33 crore from a land sale in Hyderabad. Operational performance was subdued as revenue from operations fell 26% YoY to ₹282.06 crore. Excluding the exceptional item, the core profit before tax actually declined to ₹15.78 crore from ₹19.55 crore in the previous year. A positive takeaway is the 26% reduction in finance costs, indicating better debt management.
Key Highlights
Net Profit surged 328% YoY to ₹61.51 crore, aided by a ₹64.33 crore exceptional gain from land sale.
Revenue from operations declined 25.9% YoY to ₹282.06 crore from ₹380.62 crore in Q3 FY25.
Core Profit Before Tax (excluding exceptional items) dropped 19.2% YoY to ₹15.78 crore.
Finance costs decreased by 26.3% YoY to ₹11.76 crore, down from ₹15.97 crore.
Quarterly EPS rose to ₹11.67 from ₹2.73 in the corresponding quarter of the previous year.
👀 What to Watch
Investors should not be misled by the headline profit growth as it is non-recurring; focus should remain on the declining core construction revenue. Monitor the order book and execution pace in the coming quarters to assess if the operational slowdown is temporary.
Apollo Sindoori Hotels Q3 PAT Drops 21% to ₹1.6 Cr; CEO Munish Kumar Resigns
Apollo Sindoori Hotels reported a 14.4% YoY growth in revenue to ₹92.58 crore for Q3 FY26, primarily driven by its Food & Beverages segment. However, Net Profit (PAT) declined by 21.1% YoY to ₹1.60 crore, significantly impacted by a ₹1.46 crore exceptional charge related to new Labour Code liabilities. Adding to the uncertainty, the company announced the resignation of CEO Munish Kumar, effective March 31, 2026. While the top-line shows resilience, the combination of margin pressure and leadership transition warrants a cautious outlook.
Key Highlights
Revenue from operations increased 14.4% YoY to ₹9,258.07 Lakhs in Q3 FY26.
Net Profit (PAT) fell to ₹160.33 Lakhs from ₹203.32 Lakhs in the same quarter last year.
Recognized an exceptional expense of ₹146.22 Lakhs due to incremental gratuity and leave liabilities under new Labour Codes.
CEO Munish Kumar submitted his resignation, effective from the close of business hours on March 31, 2026.
Food & Beverages segment revenue grew to ₹6,939.52 Lakhs, remaining the largest business contributor.
👀 What to Watch
Investors should monitor the company's search for a new CEO and its ability to maintain margins amidst rising employee benefit costs. The stock may face short-term volatility due to the leadership exit and the profit miss.
